The Cholangiocarcinoma Foundation and Komodo Health announced an agreement linking a cancer advocacy group with a healthcare analytics and insights delivery company to advance the treatment of cholangiocarcinoma.
Richard Pazdur, founding director of FDA’s Oncology Center of Excellence and long-time FDA visionary, has accepted the top job at FDA’s Center for Drug Evaluation and Research following George F. Tidmarsh’s dramatic ouster from the position.
